Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot Study.

Maria Elena PuglieseRiccardo BattagliaAntonio CerasaMaria Girolama RasoFrancesco CoschignanoAngela PagliusoRoberta BruschettaGiovanni PugliesePaolo ScolaPaolo Tonin

Published in: Journal of clinical medicine (2021)

Our results show an efficacy seroconversion in DOC patients in the first period after vaccination, which significantly declines over time with respect to healthy controls.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
chronic kidney disease
newly diagnosed
respiratory syndrome coronavirus
peritoneal dialysis
prognostic factors
patient reported outcomes
patient reported